Regeneron Pharmaceuticals: Pay

Regeneron Pharmaceuticals paid its 6 named executives $37.2M in total in FY2024 (Dec). CEO Leonard S. Schleifer, M.D., Ph.D. was paid $6.8M of that.

Pay$100 in the stock at the end of FY20 → $147
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Daniel P. Van PlewExecutive Vice President and General Manager, Industrial Operations and Product Supply
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
4 years
Andrew J. Murphy, Ph.D.Executive Vice President, Co-Chief Scientific Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
4 years
Leonard S. Schleifer, M.D., Ph.D.Board co-Chair, President and Chief Executive Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
4 years
George D. Yancopoulos, M.D., Ph.D.Ph.D. Board co-Chair, President and Chief Scientific Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
4 years
Christopher FenimoreExecutive Vice President, Finance and Chief Financial Officer6
FY2024 (Dec)
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 7 peers with pay on file was $28.4M. The CEO of Regeneron Pharmaceuticals was paid $7.3M, 74% below the median.

  1. 1Eli Lilly & Co
  2. 2AbbVie
  3. 3Incyte
  4. 4Gilead Sciences
  5. 5Amgen
  6. 6Bristol Myers Squibb
  7. 7Merck & Co.
  8. 8Regeneron Pharmaceuticals
  9. 9Alnylam Pharmaceuticals, Inc.Not disclosed
  10. 10BioMarin Pharmaceutical Inc.Not disclosed
  11. 11BiogenNot disclosed
  12. 12Vertex Pharmaceuticals IncorporatedNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.